The WACC of Cosmo Pharmaceuticals NV (COPN.SW) is 4.9%.
| Range | Selected | |
| Cost of equity | 3.70% - 6.10% | 4.90% |
| Tax rate | 14.60% - 20.40% | 17.50% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 3.7% - 6.1% | 4.9% |
| Category | Low | High |
| Long-term bond rate | 1.0% | 1.5% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.54 | 0.68 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 3.70% | 6.10% |
| Tax rate | 14.60% | 20.40% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 3.7% | 6.1% |
| Selected WACC | 4.9% | |